Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress–related diseases, such as atherosclerosis
Year: 2019
Type: article
Source: Human & Experimental Toxicology
Language: English
Subfield: Biochemistry (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2922123721
